These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21764347)

  • 1. Silent myocardial ischaemia and risk factors in a diabetic Afro-Caribbean population.
    Blanchet Deverly A; Amara M; Larifla L; Velayoudom-Céphise FL; Roques F; Kangambega P; Hue K; Foucan L
    Diabetes Metab; 2011 Dec; 37(6):533-9. PubMed ID: 21764347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM-SFC 2004 Guidelines in a population of diabetic patients.
    Hiebel A; Fagot-Campagna A; Fosse S; Varroud-Vial M; Weill A; Penfornis A
    Diabetes Metab; 2010 Sep; 36(4):286-92. PubMed ID: 20434384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silent myocardial ischemia in patients with diabetes: who to screen.
    Janand-Delenne B; Savin B; Habib G; Bory M; Vague P; Lassmann-Vague V
    Diabetes Care; 1999 Sep; 22(9):1396-400. PubMed ID: 10480499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients.
    Cosson E; Nguyen MT; Chanu B; Balta S; Takbou K; Valensi P
    Nutr Metab Cardiovasc Dis; 2013 Jun; 23(6):557-65. PubMed ID: 22502874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia.
    Sejil S; Janand-Delenne B; Avierinos JF; Habib G; Labastie N; Raccah D; Vague P; Lassmann-Vague V
    Diabet Med; 2006 Nov; 23(11):1186-91. PubMed ID: 17054593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.
    Tarkun I; Cetinarslan B; Cantürk Z; Tarkun P; Agaçdiken A; Komsuoglu B
    J Diabetes Complications; 2004; 18(3):165-8. PubMed ID: 15145328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of silent ischemic heart disease in patients with diabetes mellitus].
    Negrusz-Kawecka M; Moszczyńska-Stulin J; Zytkiewicz-Jaruga D; Salomon P
    Pol Merkur Lekarski; 1997 Aug; 3(14):53-6. PubMed ID: 9480174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes.
    Barthelemy O; Jacqueminet S; Rouzet F; Isnard R; Bouzamondo A; Le Guludec D; Grimaldi A; Metzger JP; Le Feuvre C
    Arch Cardiovasc Dis; 2008 Sep; 101(9):539-46. PubMed ID: 19041838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of silent coronary artery disease in type 2 diabetes.
    Zellweger MJ
    Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of echocardiographically measured left ventricular mass in diabetic patients with or without silent myocardial ischaemia.
    Sachs RN; Valensi P; Lormeau B; Taupin JM; Nitenberg A; Metz D; Talvard O; Paries J; Dali M; Leutenegger M; Attali JR
    Diabetes Metab; 1999 Jun; 25(2):128-36. PubMed ID: 10443323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Silent ischemic cardiopathy: which diabetics to examine?].
    Charpentier G; Riveline JP; Lardoux H; Mathieu E; Requeda E; Varroud-Vial M
    Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():25-32. PubMed ID: 11296459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors.
    Fornengo P; Bosio A; Epifani G; Pallisco O; Mancuso A; Pascale C
    Diabet Med; 2006 Jul; 23(7):775-9. PubMed ID: 16842483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction.
    Sukhija R; Dhanwal D; Gambhir DS; Dewan R
    Indian Heart J; 2000; 52(5):540-6. PubMed ID: 11256776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.
    Gazzaruso C; Solerte SB; De Amici E; Mancini M; Pujia A; Fratino P; Giustina A; Garzaniti A
    Am J Cardiol; 2006 Jan; 97(2):236-9. PubMed ID: 16442369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors influencing cardiac complications in patients with type-2 diabetes mellitus and silent myocardial ischaemia: five-year follow-up].
    Mamcarz A; Chmielewski M; Braksator W; Syska-Sumńska J; Janiszewski M; Król J; Kuch M; Kuch J; Dłuiniewski M
    Pol Arch Med Wewn; 2004 Dec; 112(6):1433-43. PubMed ID: 15962608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of cardiovascular risk factors in Tunisian patients with recent type 2 diabetes].
    Bouzid K; Ben Mami Ben Miled F; Hassine M; Kalai E; Ben Ahmed H; Boujnah R; Achour A; Bahlous A; Abdelmoula J
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):81-7. PubMed ID: 22172369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia.
    Valensi P; Cosson E
    Diabetes Metab; 2010 Apr; 36(2):91-6. PubMed ID: 20189425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial ischemia: a silent epidemic in Type 2 diabetes patients.
    Le Feuvre C; Jacqueminet S; Barthelemy O
    Future Cardiol; 2011 Mar; 7(2):183-90. PubMed ID: 21453025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic cardiovascular manifestations in diabetes mellitus: left ventricular diastolic dysfunction and silent myocardial ischemia.
    Seferović-Mitrović JP; Lalić NM; Vujisić-Tesić B; Lalić K; Jotić A; Ristić AD; Giga V; Tesić M; Milić N; Lukić L; Milicić T; Singh S; Seferović PM
    Srp Arh Celok Lek; 2011; 139(9-10):599-604. PubMed ID: 22069993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.